Effects of Sevoflurane vs Desflurane on Early Recovery and Cognitive Function in Elderly Patients Undergoing Scheduled Non-Cardiac Surgery
A COMPARATIVE STUDY OF DESFLURANE VERSUS SEVOFLURANE IN ELDERLY PATIENTS: EFFECT ON EARLY RECOVERY
1 other identifier
interventional
81
1 country
1
Brief Summary
The goal of this clinical study is to compare the effects of desflurane versus sevoflurane on early postoperative recovery and cognitive function in elderly patients (aged 60 years and older, ASA I-III) undergoing elective non-cardiac surgery under general anesthesia. The main questions this study aims to answer are: Which anesthetic agent allows faster emergence from anesthesia (eye opening, response to commands, extubation)? Does desflurane lead to earlier cognitive recovery as measured by the Short Orientation Memory Concentration Test (SOMCT)? Does the choice of volatile anesthetic influence the time required to achieve a modified Aldrete score (MAS) ≥ 9 and PACU discharge readiness? Researchers compared the desflurane group to the sevoflurane group to determine whether desflurane provides a superior recovery profile and minimizes delayed emergence in elderly surgical patients. Participants will: Be randomly assigned to receive either desflurane or sevoflurane for maintenance of general anesthesia. Undergo standardized induction with fentanyl, propofol, and cisatracurium, along with uniform ventilatory and monitoring protocols. Have emergence parameters recorded immediately after discontinuation of the inhaled agent (eye opening, command following, extubation). Be evaluated in the post-anesthesia care unit using the modified Aldrete Score (MAS) and SOMCT, with predefined thresholds for recovery (MAS ≥ 9, SOMCT ≥ 20). This study aims to determine whether desflurane-due to its lower blood/gas partition coefficient-offers measurable clinical benefits in terms of rapid awakening, cognitive recovery, and overall early postoperative recovery in the geriatric population.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for phase_3
Started Sep 2024
Shorter than P25 for phase_3
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
September 15, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 15, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
April 15, 2025
CompletedFirst Submitted
Initial submission to the registry
December 4, 2025
CompletedFirst Posted
Study publicly available on registry
December 17, 2025
CompletedDecember 17, 2025
December 1, 2025
7 months
December 4, 2025
December 4, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (3)
Time to eye opening
Time from discontinuation to the volatile agent to eye opening
within 3 to 24 minutes after discontinuiation of the volatile agent
Time to obey verbal command
Time from discontinuation of the volatile agent to obeying verbal command
within 5 to 40 minutes after discontinuation of the volatile agent
Time to extubation
Time from discontinuation of the volatile agent to extubation
within 6 to 30 minutes after disontinuation of the volatile agent
Secondary Outcomes (3)
Time to reach a Modified Aldrete Score 9 or greater
within 10 to 48 minutes after discontinuation of the volatile agent
Time to discharge from the recovery room
within 12 to 53 minutes after discontinuation of the volatile agent
Time to reach a SOMCT 20 or higher
within 15 to 55 minutes from discontinuation of the volatile agent
Study Arms (2)
sevoflurane group
ACTIVE COMPARATORParticipants receive Sevoflurane for anesthesia maintenance with a Fresh Gaz Flow of less than 1 L/min.
Desflurane group
ACTIVE COMPARATORParticipants receive Desflurane for anesthesia maintenance with a Fresh Gaz Flow of less than 0.5 L/min.
Interventions
Sevoflurane used for anesthesia maintenance with a MAC of 2-3% and FGF of less than 1 L/min.
Desflurane used for anesthesia maintenance with a MAC of 4-6% and FGF of less than 0.5 L/min.
Eligibility Criteria
You may qualify if:
- Elderly patients whose ages are superior to 60 years of age \[1\].
- Patients with an American Society of Anesthesiologists Classification (ASA) I, II or III stable (Annex 1).
- Patients undergoing elective non-cardiac surgery under general anesthesia with tracheal intubation.
- Patients having declined to participate in the study protocol.
- Patients with a contraindication for minimal flow anesthesia such as hyperthermia, smoke intoxication and ketoacidosis metabolic condition (for example, anorexia nervosa).
- Patients with history of malignant hyperthermia.
- Patients with Psychotic disorders.
- Patients with substance abuse.
- Patients with severe obstructive or restrictive pulmonary disease.
- Patients with hepatic disease.
- Patients with end stage renal disease.
- Patients with history of allergy to study drugs.
You may not qualify if:
- We excluded from our study patients who presented with perioperative complication or instability requiring ICU transfer due to extubation failure.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Hospital of Charles Nicolle, Tunis, Tunis 1006
Tunis, Tunis Governorate, 1006, Tunisia
Related Publications (11)
Kim CT, Myung W, Lewis M, Lee H, Kim SE, Lee K, Lee C, Choi J, Kim H, Carroll BJ, Kim DK. Exposure to General Anesthesia and Risk of Dementia: A Nationwide Population-Based Cohort Study. J Alzheimers Dis. 2018;63(1):395-405. doi: 10.3233/JAD-170951.
PMID: 29614656BACKGROUNDKatzman R, Brown T, Fuld P, Peck A, Schechter R, Schimmel H. Validation of a short Orientation-Memory-Concentration Test of cognitive impairment. Am J Psychiatry. 1983 Jun;140(6):734-9. doi: 10.1176/ajp.140.6.734.
PMID: 6846631BACKGROUNDJindal R, Kumra VP, Narani KK, Sood J. Comparison of maintenance and emergence characteristics after desflurane or sevoflurane in outpatient anaesthesia. Indian J Anaesth. 2011 Jan;55(1):36-42. doi: 10.4103/0019-5049.76604.
PMID: 21431051BACKGROUNDKaur A, Jain AK, Sehgal R, Sood J. Hemodynamics and early recovery characteristics of desflurane versus sevoflurane in bariatric surgery. J Anaesthesiol Clin Pharmacol. 2013 Jan;29(1):36-40. doi: 10.4103/0970-9185.105792.
PMID: 23493107BACKGROUNDSaha M, Saxena KN, Wadhwa B. Comparative study of recovery of airway reflexes and cognitive function following sevoflurane versus desflurane anaesthesia. Indian J Anaesth. 2021 Apr;65(4):282-288. doi: 10.4103/ija.IJA_1219_20. Epub 2021 Apr 15.
PMID: 34103741BACKGROUNDLa Colla L, Albertin A, La Colla G, Mangano A. Faster wash-out and recovery for desflurane vs sevoflurane in morbidly obese patients when no premedication is used. Br J Anaesth. 2007 Sep;99(3):353-8. doi: 10.1093/bja/aem197. Epub 2007 Jul 9.
PMID: 17621601BACKGROUNDWhite PF, Tang J, Wender RH, Yumul R, Stokes OJ, Sloninsky A, Naruse R, Kariger R, Norel E, Mandel S, Webb T, Zaentz A. Desflurane versus sevoflurane for maintenance of outpatient anesthesia: the effect on early versus late recovery and perioperative coughing. Anesth Analg. 2009 Aug;109(2):387-93. doi: 10.1213/ane.0b013e3181adc21a.
PMID: 19608808BACKGROUNDGangakhedkar GR, Monteiro JN. A prospective randomized double-blind study to compare the early recovery profiles of desflurane and sevoflurane in patients undergoing laparoscopic cholecystectomy. J Anaesthesiol Clin Pharmacol. 2019 Jan-Mar;35(1):53-57. doi: 10.4103/joacp.JOACP_375_17.
PMID: 31057241BACKGROUNDWang C, Li L, Xu H, Lv H, Zhang H. Effect of desflurane-remifentanil or sevoflurane-remifentanil on early recovery in elderly patients: a meta-analysis of randomized controlled trials. Pharmazie. 2019 Apr 1;74(4):201-205. doi: 10.1691/ph.2019.8935.
PMID: 30940302BACKGROUNDLockwood G. Theoretical context-sensitive elimination times for inhalation anaesthetics. Br J Anaesth. 2010 May;104(5):648-55. doi: 10.1093/bja/aeq051. Epub 2010 Mar 16.
PMID: 20233751BACKGROUNDWagner S, Breitkopf M, Ahrens E, Ma H, Kuester O, Thomas C, von Arnim CAF, Walther A. Cognitive function in older patients and their stress challenge using different anesthesia regimes: a single center observational study. BMC Anesthesiol. 2023 Jan 6;23(1):6. doi: 10.1186/s12871-022-01960-7.
PMID: 36609226BACKGROUND
Related Links
- World Health Organization. World Health Statistics 2016: Monitoring Health for the Sustainable Development Goals
- National Library of Medicine. Sevoflurane \[Online\]. Bethesda (MD): National Center for Biotechnology Information
- Effect of desflurane and sevoflurane on postoperative cognitive dysfunction: A meta-analysis of randomized controlled trials
MeSH Terms
Interventions
Intervention Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- phase 3
- Allocation
- RANDOMIZED
- Masking
- TRIPLE
- Who Masked
- PARTICIPANT, CARE PROVIDER, OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Head of Anesthesiology and Intensive Care Department at Charles Nicolle Hospital in Tunis
Study Record Dates
First Submitted
December 4, 2025
First Posted
December 17, 2025
Study Start
September 15, 2024
Primary Completion
April 15, 2025
Study Completion
April 15, 2025
Last Updated
December 17, 2025
Record last verified: 2025-12